TABLE 5.
Conjugated Bilirubin (mg/dL) 0.5–1.9 (N=4535) | Conjugated Bilirubin (mg/dL) 2–4.9 (N=167) | Conjugated Bilirubin (mg/dL) ≥ 5 (N=73) | |||
---|---|---|---|---|---|
Diagnostic Categories | Percent | Diagnostic Categories | Percent | Diagnostic Categories | Percent |
No dx associated with cholestasis† | 96% | No dx associated with cholestasis† | 69% | Biliary disorder | 47% |
Severe bacterial infection† | 2% | Liver disease | 11% | Liver disease | 42% |
GI abnormality | 1% | Biliary disorder | 10% | GI abnormality | 27% |
Liver disease | 0.3% | GI abnormality | 10% | No dx associated with cholestasis† | 27% |
Biliary disorder | 0.2% | Severe bacterial infection† | 10% | Severe bacterial infection‡ | 18% |
Viral hepatitis | 0.04% | Viral hepatitis | 2% | Viral hepatitis | 6% |
A single subject may have more than one ICD-9 diagnosis associated with cholestasis
Signifies that there was no ICD-9 code in disease categories associated with cholestasis
Includes codes for diseases such as septicemia, meningitis and bacteremia